INTRODUCTION AND OBJECTIVES: The implantation of bioresorbable scaffolds ( @entity4375 ) is an emerging technique used in percutaneous coronary interventions. Their application has been extended to more complex lesions, although evidence is only available for simple lesions. The present study evaluated scaffold implantation in long lesions, focusing on overlapping scaffolds. METHODS: We retrospectively analyzed all consecutive @entity1 eligible for stenting with @entity2239 -eluting @entity7049 -based @entity4375 with a minimum total scaffold length of 28mm, irrespective of the number of @entity4375 used. The main target parameters were major adverse @entity299 , comprising @entity204 , any @entity583 , and @entity75 revascularization, and @entity75 failure, including @entity204 , target vessel @entity583 , and @entity75 revascularization. A subgroup analysis included @entity1 with overlapping @entity4375 . RESULTS: A total of 250 @entity1 were included. The reason for angiography was stable @entity453 in 36.4% (91 of 250), an @entity1187 in 61.6% (154 of 250), and other reasons in 2.0% (5 of 250). Procedural success was achieved in 97.8% (267 of 273) of the lesions. During follow-up, the 12-month rates of major adverse @entity299 , @entity75 failure, and scaffold @entity715 were 8.5%, 6.6%, and 2.3%, respectively. Subgroup analysis of 239 @entity1 showed that there were no statistically relevant differences between @entity1 with and without overlapping scaffolds after a 12-month follow-up. CONCLUSIONS: Long-segment stenting with a single scaffold or with multiple overlapping scaffolds is technically feasible with adequate mid-term outcomes. However, large-scale randomized studies are needed to provide further proof of concept.

Outcome After Long-segment Stenting With XXXX -eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1187 :: ('MESH:D054058', 'Disease') :: ['acute coronary syndrome'] @entity75 :: ('MESH:D001927', 'Disease') :: ['target lesion'] @entity4375 :: ('11246', 'Species') :: ['BRS'] @entity7049 :: ('MESH:C010506', 'Chemical') :: ['poly-L-lactic acid'] @entity2239 :: ('MESH:C107135', 'Chemical') :: ['everolimus'] @entity453 :: ('MESH:D003324', 'Disease') :: ['coronary artery disease'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac events', 'cardiac event'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction'] @entity204 :: ('MESH:D003643', 'Disease') :: ['cardiac death'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis']
@entity2239 :: (MESH:C107135,Chemical) :: ['Everolimus']
